Ossopan 1100 By XYMOGEN Overview & Drug Interactions

Check For Interactions With Ossopan 1100

Supplement: Ossopan 1100 by XYMOGEN

Ossopan 1100 Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Ossopan 1100 by XYMOGEN

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container 60
UPC/BARCODE 871149001940

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Calcium
550 mg
Calcium 42%
Phosphorus
198 mg
Phosphorus 16%
MCHC
2.2 Gram(s)
Calcium --
Microcrystalline Hydroxyapatite
1.32 Gram(s)
Calcium --

Other Ingredients:
Hypromellose
Water
Stearic Acid
Medium Chain Triglyceride Oil
Microcrystalline Cellulose
Magnesium Stearate
Silica


Label Statments:


Precautions
- Professional use only Not for resale on third-party websites, including, but not limited to, Amazon and eBay.
- Consult your health care professional prior to use.
- Individuals taking medication should discuss potential interactions with their healthcare professional.
- Do not use of tamper seal is damaged. The labeling on this product does not comply with California's proposition 65. Therefore, this product may not be sold in California.
- Storage: keep tightly closed in a cool, dry place out of reach of children.
Suggested/Recommended/Usage/Directions
- Directions: take one to two capsules up to two times daily, or as directed by your healthcare professional.
Formula
- Ossopan Is a well-researched, standardized extract from one of the world's safest premium sources of bone-free-range New Zealand cattle. Ossopan contains microcrystalline hydroxyapatite concentrate (MCHC), a complex crystalline compound composed primarily of calcium, phosphorus, bioactive growth factors, type I collagen, amino acids, glycosaminoglycans, and a broad range of essential trace elements that naturally comprise healthy bone. Ossopan 1100 Provides 1100 mg of MCHC per capsule to optimally support bone strength and structure.
- Microcrystalline hydroxyapatite concentrate MCHC
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Storage
- Storage: keep tightly closed in a cool, dry place out of reach of children.
Formulation
- Formulated to exclude: wheat, gluten, corn, yeast, soy, dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.
- Vegetarian caps
FDA Statement of Identity
- Dietary Supplement
Seals/Symbols
- ePV (ePedigree Verification)
- Vegetarian caps Third-party GMP compliant verified
Brand IP Statement(s)
- Exclusive professional formulas S1. Microcrystalline hydroxyapatite concentrate. Copyright 2020 XYMOGEN
General Statements
- Scan to learn more! This package is completely recyclable

Brand Information

See all products by this brand

Manufacturer
Name XYMOGEN Exclusive Professional Formulas
Street Address 6900 Kingspointe Pkwy.
City Orlando
State FL
ZipCode 32819
Phone Number 800-647-6100
Web Address www.xymogen.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.